Alyeska discloses 9.99% Solidion Technology (STI) stake with warrant overhang

Rhea-AI Filing Summary

Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh reported beneficial ownership of Solidion Technology, Inc. common stock. As of 30 June 2026 they beneficially own 848,718 shares of common stock, representing 9.99% of the outstanding class, all with shared voting and dispositive power. This position consists of 678,788 shares acquired in a private placement and 169,930 shares issuable upon exercise of pre-funded warrants. The reporting persons also hold pre-funded warrants exercisable for an additional 1,583,000 shares, but a 9.99% beneficial ownership limitation restricts further exercise based on 8,495,683 shares of common stock outstanding, as referenced from a Form 424B3 dated 23 June 2026. The position is held by Alyeska Master Fund, L.P., with Alyeska Investment Group, L.P. exercising voting and investment control; Anand Parekh may be deemed a beneficial owner but disclaims beneficial ownership.

Key Figures

Beneficially owned shares: 848,718 shares Percent of class: 9.99% Private placement shares: 678,788 shares +4 more

7 metrics

Beneficially owned shares 848,718 shares Common stock beneficially owned as of 30 June 2026

Percent of class 9.99% Portion of Solidion common stock class beneficially owned

Private placement shares 678,788 shares Common shares acquired in a private placement

Beneficially owned warrant shares 169,930 shares Shares issuable upon exercise of pre-funded warrants within 9.99% cap

Total warrant capacity 1,583,000 shares Shares exercisable under pre-funded warrants, subject to ownership limit

Shares outstanding 8,495,683 shares Solidion common stock outstanding per Form 424B3 dated 23 June 2026

Beneficial ownership cap 9.99% Limit in pre-funded warrants on total beneficial ownership

Key Terms

beneficial ownership limitation, pre-funded warrants, shared voting power, Schedule 13G

4 terms

beneficial ownership limitation regulatory

"such warrants contain a beneficial ownership limitation that prohibits exercise"

A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.

pre-funded warrants financial

"169,930 shares issuable upon exercise of pre-funded warrants"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

shared voting power regulatory

"Shared Voting Power 848,718.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

Schedule 13G regulatory

"JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k)"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What percentage of Solidion Technology, Inc. (STI) does Alyeska report owning?

Alyeska and related reporting persons report beneficial ownership of 9.99% of Solidion Technology, Inc. common stock, based on 8,495,683 shares outstanding as referenced from a Form 424B3 dated 23 June 2026.

How many Solidion Technology (STI) shares does Alyeska beneficially own?

The reporting persons beneficially own 848,718 shares of Solidion Technology common stock, including shares held outright and shares issuable upon exercise of pre-funded warrants, all subject to a 9.99% beneficial ownership cap.

What portion of Alyeska’s STI position comes from a private placement?

Alyeska’s reported position includes 678,788 shares of Solidion Technology common stock acquired in a private placement, forming the majority of their total 848,718-share beneficial ownership stake.

How many Solidion Technology (STI) shares are tied to Alyeska’s pre-funded warrants?

The reporting persons hold pre-funded warrants exercisable for 1,583,000 shares of Solidion Technology, but only 169,930 shares are currently counted as beneficially owned due to a 9.99% ownership limitation.

What is the beneficial ownership limitation affecting Alyeska’s STI warrants?

The pre-funded warrants include a 9.99% beneficial ownership limitation, preventing exercise if it would raise the holder’s beneficial ownership above 9.99% of Solidion’s 8,495,683 outstanding common shares.

Who exercises voting and investment control over Alyeska’s STI position?

Shares are held by Alyeska Master Fund, L.P., while Alyeska Investment Group, L.P. as investment manager exercises voting and investment control. Anand Parekh may be deemed a beneficial owner but disclaims beneficial ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:27 PM Accepted by SEC EDGAR 08/14/2026 - 04:20 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

SOLIDION TECHNOLOGY, INC.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

834212201

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 834212201

1

Names of Reporting Persons

Alyeska Investment Group, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 848,718.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 848,718.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

848,718.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 834212201

1

Names of Reporting Persons

Alyeska Fund GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 848,718.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 848,718.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

848,718.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 834212201

1

Names of Reporting Persons

Anand Parekh

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 848,718.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 848,718.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

848,718.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: SOLIDION TECHNOLOGY, INC.
(b)	Address of issuer's principal executive offices: 13355 Noel Road, Suite 1100, Dallas, TX 75240
Item 2.
(a)	Name of person filing: (i) Alyeska Investment Group, L.P. (ii) Alyeska Fund GP, LLC (iii) Anand Parekh
(b)	Address or principal business office or, if none, residence: (i) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (ii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (iii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601
(c)	Citizenship: (i) Alyeska Investment Group, L.P. - Delaware (ii) Alyeska Fund GP, LLC - Delaware (iii) Anand Parekh - United States of America
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP Number(s): 834212201
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 848,718
(b)	Percent of class: 9.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 848,718
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 848,718
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alyeska Investment Group, L.P.

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	08/14/2026

Alyeska Fund GP, LLC

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	08/14/2026

Anand Parekh

Signature:	Anand Parekh
Name/Title:	Anand Parekh | Self
Date:	08/14/2026

Exhibit Information

As of 30 June 2026, the Reporting Persons beneficially own 848,718 shares of Common Stock, consisting of (i) 678,788 shares of Common Stock acquired in a private placement and (ii) 169,930 shares issuable upon exercise of pre-funded warrants. The Reporting Persons hold pre-funded warrants exercisable for 1,583,000 shares; however, such warrants contain a beneficial ownership limitation that prohibits exercise to the extent it would cause the holder's beneficial ownership to exceed 9.99% of the outstanding Common Stock. Based on 8,495,683 shares of Common Stock outstanding (per the Form 424B3 dated 23 June 2026), the 9.99% limitation permits exercise of only 169,930 warrant shares after giving effect to the 678,788 shares otherwise held. Position held by Alyeska Master Fund, L.P. Alyeska Investment Group, L.P., as investment manager, exercises voting and investment control over the shares held by Alyeska Master Fund, L.P. Anand Parekh, as Chief Executive Officer of Alyeska Investment Group, L.P., may be deemed the beneficial owner of such shares. Mr. Parekh disclaims beneficial ownership of such shares. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.